Hossfeld, Dieter K.

A
– (BLUMENSTEIN, M, TESSMER, U, HOSSFELD, D. K., DÜHRSEN, U.) Intracisternal A-particle (IAP) mediated leukemogenesis: Levels and stability of IAP mRNA in FDC-P1 cells exposed to the conditions of an irradiated environment. – Cell Biol. Intern. 22, S. 563-574.
– (ZHANG W., KNIELING, G., VOHWINKEL, G., MARTINEZ, T., KUSE, R., HOSSFELD, D.K., DÜHRSEN, U.) Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia. – Ann. Hematol. 78, S. 305-314.
– (JUNGINGER, T., HOSSFELD, D. K., SAUER, R., HERMANEK, P.) Adjuvante Therapie bei Kolon- und Rektumkarzinom. – Deutsch. Ärztebl. 96, A698-A700.
– (HERMANEK, P., JUNGINGER, T., HOSSFELD, D. K., MÜLLER, R. P., FÖLSCH, U. R.) Nachsorge und Rehabilitation bei Patienten mit gastrointestinalen Tumoren. – Deutsch. Ärztebl. 96, A2084-A2088.
– (MROSS, K., KRÖGER, N., HERBST, K., GASTL, G., HOSSFELD, D. K.) Alteration in epirubicin pharmacokinetics and metabolism by dexverapamil: Results from a phase II study in patients with metastatic breast cancer. – Onkologie 23, S. 35-40.
– (DIERLAMM, J., WLODARSKA, I., MICHAUX, L., STEFANOVA, M., SEEGER, D., HINZ, K., HAGEMEIJER, J., HOSSFELD, D. K.) Fluorescence in situ hybridization (FISH): A powerful method for the detection of genetic abnormalities in metaphases and in inter-phase nuclei. – Infusionsther. Transfusionsmed. 26, S. 146-150.
– (DIERLAMM, J., MICHAUX, L., STEFANOVA, S., EGGERT, J., LEBERECHT, P., SEEGER, D., WESTERHAUSEN, M., HOSSFELD, D. K.) Novel Philadelphia variant t(Y;9;22)(q12;q34;q11) in a case of chronic myeloid leukemia. – Cancer Genet. Cytogenet. 114, S. 150-153.
– (WOLF, G., HEGEWISCH-BECKER, S., HOSSFELD, D. K., STAHL, R. A. K.) Hyperuricemia and renal insufficiency associated with malignant disease: Urate oxidase as an efficient therapy? – Amer. J. Kidney Disesaes 34, E20, S. 1-6.
– Welchen Stellenwert hat die Hodosis-Chemotherapie des Mammakarzinoms? – Deutsch. Ärtzebl. 96, A12.
– (GRAEVEN, U., FIEDLER, W., KARPINSKI, S., ERGÜN, S., KILIC, N., RODECK, U., SCHMIEGEL, W., HOSSFELD, D. K.) Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR. – J. Cancer Res. Clin. Oncol. 125, S. 621-629.
– (RUMMEL, M., CHOW, K. U., JÄGER, E., LEIMER, L., HOSSFELD, D. K., BERGMANN, L., PETERS, H. D., HANSMANN, M. L., MEYER, A., HOELZER, D., MITROU, P.) Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas. – Leukemia Lymphoma 35, S. 129-138.
– (BÜCHNER, T., HIDDEMANN, W., WÖRMANN, B., LÖFFLER, H., GASSMANN, W., HAFERLACH, T., FONATSCH, C., HAASE, D., SCHOCH, C., HOSSFELD, D. K., LENGFELDER, E., AUL, C., HEYLL, A., MASCHMEYER, G., LUDWIG, W. D., SAUERLAND, M. C., HEINECKE, A.) Double induction strategy for acute myeloid leukemia: The effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicine and 6-thioguanine: A randomized trial by the German AML cooperative group. – Blood 93, S. 4116-4124.
– (CLAUSEN, M., HOSSFELD, D. K., SCHUMACHER, U.) Molekular-Tumorbiologie: Modellsysteme zur Erforschung der metastatischen Kaskade. – medizin 2000 1, S. 12-15.